To get the team

Head of Life Sciences Practice

What he specialises in

Konstantin has more than 13 years of experience in law, for nine of which he has been providing legal assistance to pharmaceutical companies in Russia and the CIS. He specialises in transactions with assets in the area of pharmaceuticals, solving complex regulatory issues, including those connected with intellectual property of pharmaceutical companies, with the localisation of manufacturing in Russia, and with contractual regulation of relationships between those involved in the circulation of medicines and medical products in Russia.

Konstantin has vast experience of representing clients in negotiations, within the framework of complaint proceedings and in litigation, including disputes with supervisory authorities.

His key achievements

Among Konstantin’s major projects are:

  • provided successful legal support for a major transaction on the market of Russia and the CIS with respect to the disposal of a portfolio of medicines, and other transactions with assets in Russia and the CIS;

  • provided legal support for localisation of the manufacturing of medicines and medical products from production sites in the EU to production sites in Russia;

  • was actively involved in the development of recommendations to apply legislation on the advertising of OTC medicines adopted by major associations of pharmaceutical producers under the auspices of the FAS (the Russian Federal Antimonopoly Service);

  • prepared legal opinions on various issues related to launching original and generic drugs on the market, and registering biologically active supplements and medical products;

  • developed and implemented commercial and credit policies of a pharmaceutical company in Russia and the CIS.

What they say

Pepeliaev Group's team exhibits “excellent value for money and a result-oriented approach” (Legal 500).

Pepeliaev Group opens its Middle East Desk with an office in Dubai
Read more
Pepeliaev Group’s key projects in 2022
Read more
Aydar Sultanov has joined Pepeliaev Group's team
Read more